Literature DB >> 15312673

The intracellular antibody capture technology: towards the high-throughput selection of functional intracellular antibodies for target validation.

Michela Visintin1, Michele Quondam, Antonino Cattaneo.   

Abstract

Several approaches have been developed over the past decade to study the complex interactions that occur in biological system. The ability to carry out a comprehensive genetic analysis of an organism becomes more limited and difficult as the complexity of the organism increases because complex organisms are likely to have not only more genes than simple organisms but also more elaborate networks of interactions among those genes. The development of technologies to systematically disrupt protein networks at the genomic scale would greatly accelerate the comprehensive understanding of the cell as molecular machinery. Intracellular antibodies (intrabodies) can be targeted to different intracellular compartments to specifically interfere with function of selected intracellular gene products in mammalian cells. This technique should prove important for studies of mammalian cells, where genetic approaches are more difficult. In the context of large-scale protein interaction mapping projects, intracellular antibodies (ICAbs) promise to be an important tool to knocking out protein function inside the cell. In this context, however, the need for speed and high throughput requires the development of simple and robust methods to derive antibodies which function within cells, without the need for optimization of each individual ICAb. The successful inhibition of biological processes by intrabodies has been demonstrated in a number of different cells. The performance of antibodies that are intracellularly expressed is, however, somewhat unpredictable, because the reducing environment of the cell cytoplasm in which they are forced to work prevents some antibodies, but not others, to fold properly. For this reason, we have developed an in vivo selection procedure named Intracellular Antibody Capture Technology (IACT) that allows the isolation of functional intrabodies. The IAC technology has been used for the rapid identification of antigen-antibody pairs in intracellular compartments and for the in vivo identification of epitopes recognized by the selected intracellular antibodies. Several optimizations of the IAC technology for protein knock-out have been developed so far. This system offers a powerful and versatile proteomic tool to dissect diverse functional properties of cellular proteins in different cell lines.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15312673     DOI: 10.1016/j.ymeth.2004.04.008

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  17 in total

Review 1.  Targeting antibodies to the cytoplasm.

Authors:  Andrea L J Marschall; André Frenzel; Thomas Schirrmann; Manuela Schüngel; Stefan Dübel
Journal:  MAbs       Date:  2011-01-01       Impact factor: 5.857

Review 2.  Therapeutic antibodies: successes, limitations and hopes for the future.

Authors:  Patrick Chames; Marc Van Regenmortel; Etienne Weiss; Daniel Baty
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

3.  A strategy for adenovirus vector targeting with a secreted single chain antibody.

Authors:  Joel N Glasgow; Galina Mikheeva; Victor Krasnykh; David T Curiel
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

4.  Changing the subcellular location of the oncoprotein Bcr-Abl using rationally designed capture motifs.

Authors:  Andrew S Dixon; Jonathan E Constance; Tomoyuki Tanaka; Terence H Rabbitts; Carol S Lim
Journal:  Pharm Res       Date:  2011-12-20       Impact factor: 4.200

5.  Selection for intrabody solubility in mammalian cells using GFP fusions.

Authors:  Laurence Guglielmi; Vincent Denis; Nadia Vezzio-Vié; Nicole Bec; Piona Dariavach; Christian Larroque; Pierre Martineau
Journal:  Protein Eng Des Sel       Date:  2011-10-13       Impact factor: 1.650

6.  The use of phage display to generate conformation-sensor recombinant antibodies.

Authors:  Aftabul Haque; Nicholas K Tonks
Journal:  Nat Protoc       Date:  2012-11-15       Impact factor: 13.491

7.  Characterization of single chain antibody targets through yeast two hybrid.

Authors:  Ole Vielemeyer; Clément Nizak; Ana Joaquina Jimenez; Arnaud Echard; Bruno Goud; Jacques Camonis; Jean-Christophe Rain; Franck Perez
Journal:  BMC Biotechnol       Date:  2010-08-22       Impact factor: 2.563

8.  A focused antibody library for selecting scFvs expressed at high levels in the cytoplasm.

Authors:  Pascal Philibert; Audrey Stoessel; Wei Wang; Annie-Paule Sibler; Nicole Bec; Christian Larroque; Jeffery G Saven; Jérôme Courtête; Etienne Weiss; Pierre Martineau
Journal:  BMC Biotechnol       Date:  2007-11-22       Impact factor: 2.563

9.  Characterization of antibodies in single-chain format against the E7 oncoprotein of the human papillomavirus type 16 and their improvement by mutagenesis.

Authors:  Maria Gabriella Donà; Colomba Giorgi; Luisa Accardi
Journal:  BMC Cancer       Date:  2007-01-31       Impact factor: 4.430

10.  Gephyrin selective intrabodies as a new strategy for studying inhibitory receptor clustering.

Authors:  Paola Zacchi; Elena Dreosti; Michela Visintin; Matteo Moretto-Zita; Ivan Marchionni; Isabella Cannistraci; Zeynep Kasap; Heinrich Betz; Antonino Cattaneo; Enrico Cherubini
Journal:  J Mol Neurosci       Date:  2007-11-16       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.